Literature DB >> 28041315

Anatomic and functional imaging in the diagnosis of spine metastases and response assessment after spine radiosurgery.

Moaaz Soliman1, Neil K Taunk2, Robert E Simons1, Joseph R Osborne3, Michelle M Kim1, Nicholas J Szerlip4, Daniel E Spratt1.   

Abstract

Spine stereotactic radiosurgery (SSRS) has recently emerged as an increasingly effective treatment for spinal metastases. Studies performed over the past decade have examined the role of imaging in the diagnosis of metastases, as well as treatment response following SSRS. In this paper, the authors describe and review the utility of several imaging modalities in the diagnosis of spinal metastases and monitoring of their response to SSRS. Specifically, we review the role of CT, MRI, and positron emission tomography (PET) in their ability to differentiate between osteoblastic and osteolytic lesions, delineation of initial bony pathology, detection of treatment-related changes in bone density and vertebral compression fracture after SSRS, and tumor response to therapy. Validated consensus guidelines defining the imaging approach to SSRS are needed to standardize the diagnosis and treatment response assessment after SSRS. Future directions of spinal imaging, including advances in targeted tumor-specific molecular imaging markers demonstrate early promise for advancing the role of imaging in SSRS.

Entities:  

Keywords:  ADC = apparent diffusion coefficient; DCE-MRI = dynamic contrast-enhanced MRI; DWI = diffusion-weighted imaging; MDA = MD Anderson; PET = positron emission tomography; RECIST = Response Evaluation Criteria in Solid Tumors; RT = radiation therapy; SPINO = Spine Response Assessment in Neuro-Oncology; SSRS = spine stereotactic radiosurgery; STIR = short tau inversion recovery; VCF = vertebral compression fracture; imaging; spine metastases; stereotactic body radiotherapy; treatment response

Mesh:

Year:  2017        PMID: 28041315     DOI: 10.3171/2016.9.FOCUS16350

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Added Value of Contrast Medium in Whole-Body Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Comparison between Contrast-Enhanced and Non-Contrast-Enhanced Protocols.

Authors:  Filiz Celebi; Emetullah Cindil; Dauren Sarsenov; Bulent Unalan; Cem Balcı
Journal:  Med Princ Pract       Date:  2019-06-17       Impact factor: 1.927

2.  Changes in Volume and Density Parameters Measured on Computed Tomography Images Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases.

Authors:  Samuel Finkelstein; Srinivas Raman; Joanne Van Der Velden; Liying Zhang; Carolyn Tan; Amanpreet Dhillon; Frances Tonolete; Nicholas Chiu; Linda Probyn; Rachel McDonald; Arjun Sahgal; Edward Chow; Lee Chin
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 3.  Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis.

Authors:  Jang Bae Moon; Su Woong Yoo; Changho Lee; Dong-Yeon Kim; Ayoung Pyo; Seong Young Kwon
Journal:  Cells       Date:  2021-10-25       Impact factor: 6.600

4.  Diagnostic Accuracy of Quantitative Imaging Biomarkers in the Differentiation of Benign and Malignant Vertebral Lesions : Combination of Diffusion-Weighted and Proton Density Fat Fraction Spine MRI.

Authors:  Frederic Carsten Schmeel; Simon Jonas Enkirch; Julian Alexander Luetkens; Anton Faron; Nils Lehnen; Alois Martin Sprinkart; Leonard Christopher Schmeel; Alexander Radbruch; Ulrike Attenberger; Guido Matthias Kukuk; Petra Mürtz
Journal:  Clin Neuroradiol       Date:  2021-03-31       Impact factor: 3.649

5.  Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study.

Authors:  Dora Correia; Barbara Moullet; Jennifer Cullmann; Rafael Heiss; Ekin Ermiş; Daniel M Aebersold; Hossein Hemmatazad
Journal:  Radiat Oncol       Date:  2022-02-21       Impact factor: 3.481

Review 6.  [Diffusion-Weighted Magnetic Resonance Imaging of Spine].

Authors:  Young Cheol Yoon
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-01-31

7.  What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer?

Authors:  Filiz Çelebi
Journal:  Eur J Breast Health       Date:  2019-10-01

Review 8.  Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues.

Authors:  A Nervo; A Ragni; F Retta; M Gallo; A Piovesan; V Liberini; M Gatti; U Ricardi; D Deandreis; E Arvat
Journal:  J Endocrinol Invest       Date:  2020-08-03       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.